Does intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation predict adverse effects during 'pill-in-the-pocket ' treatment?
The patient's tolerance of intravenous administration of flecainide or propafenone does not seem to predict adverse effects during out-of-hospital self-administration of these drugs.
Even though an ovulation-related salivary testosterone peak was observed in individual cases, no significant effect was found on a group level.